CMAHP and diabetes mellitus: In particular, expressions of lipid metabolism, small molecule biochemistry, inflammatory response, and cell death and survival genes were significantly increased in Cmah-null mouse-derived livers, leading to the development of metabolic syndrome, that is, central obesity, carbohydrate intolerance, type 2 diabetes mellitus, and dyslipidemia.